Global WACh Co-Directors, Dr. Irene Njuguna and Grace John-Stewart, are Multiple Principal Investigators of a new five-year National Institutes of Health award for “Impact of HIV and toxic metals exposure on neurodevelopment at school age (HOPE-X).” 

For people living with HIV (PLWH) in Africa, hypertension (HTN) is the leading cause of cardiovascular morbidity and mortality. However, despite increased access to effective antiretroviral therapy (ART), PLWH in Africa have limited access to high-quality care for cardiovascular diseases such as strokes, heart failure, and kidney diseases.  

As scientists, clinicians, policy makers and activists gathered this week in Brisbane, Australia, for a conference on HIV/AIDS, all of them certainly expected to hear about the latest scientific advancements. Many of them probably used some of their free time to explore the rich cultural offerings of the host city. Probably only a few, though, imagined that they could view an exhibition that explored HIV/AIDS through art.

Elizabeth Bukusi, research professor of global health and obstetrics and gynecology in the UW School of Medicine, is quoted.

A new grant will help deliver HIV prevention services to people in Uganda who are injecting drugs.

Renee Heffron and Andrew Mujugira are key personnel on the grant, which will support research through 2025. The project will implement pre-exposure prophylaxis (PrEP), train a mental health staff, and also include project implementation, data collection, stakeholder engagement, and dissemination of the results to communities.